Acceptability of the Human Papillomavirus Vaccine Among Urban Adolescent Males

American Journal of Men's Health

Volumn 7, Issue 1, 2013, Pages 27-36

  Gutierrez, Baudelio ^a   Leung, Anthony ^a   Jones, Kevin Trimell ^b   Smith, Peter ^b   Silverman, Randee ^b   Frank, Ian ^b   Leader, Amy E ^c  

^a DREXEL UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

HPV vaccine; human papillomavirus; male sexual health; men who have sex with men (MSM); theory of planned behavior

Indexed keywords

EID: 84871336517     PISSN: 15579883     EISSN: 15579891     Source Type: Journal    
DOI: 10.1177/1557988312456697     Document Type: Article

References (34)

1. Ajzen I.The theory of planned behavior.Organizational Behavior and Human Decision Processes. 1991;50:179-211.
2. Allen J. D.,Fantasia H. C.,Fontenot H.,Flaherty S.,Santana J.College men's knowledge, attitudes, and beliefs about the human papillomavirus infection and vaccine.Journal of Adolescent Health. 2009;45:535-537.
3. Blum R. W.Mother's influence on teen sex: Connections that promote postponing sexual intercourse. Minneapolis: Center for Adolescent Health, University of Minnesota; 2002:.
4. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).Morbidity and Mortality Weekly Report. 2010;59:630-632.
5. Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP).Morbidity and Mortality Weekly Report. 2011a;60:1705-1708.
6. Centers for Disease Control and Prevention. (2011b). STD trends in the United States: 2010 National data for gonorrhea, chlamydia, and syphilis. Retrieved from http://www.cdc.gov/std/stats10/trends2010.pdf.
7. Dietz C. A.,Nyberg C. R.Genital, oral, and anal human papillomavirus infection in men who have sex with men.Journal of the American Osteopathic Association. 2011;111:S19-S25.
8. Dunne E. F.,Markowitz L. E.Genital human papillomavirus infection.Clinical Infectious Diseases. 2006;43:624-629.
9. Ferris D. G.,Waller J. L.,Miller J.,Patel P.,Price G. A.,Jackson L.,Wilson C.Variables associated with human papillomavirus (HPV) vaccine acceptance by men.Journal of the American Board of Family Medicine. 2009;22:34-42.
10. U.S. Food and Drug Administration. (2009). FDA approves new indication for Gardasil to prevent genital warts in men and boys. FDA: News and events. Retrieved from http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm187003.htm.
11. Gerend M. A.,Barley J.Human papillomavirus vaccine acceptability among young adult men.Sexually Transmitted Diseases. 2009;36:58-62.
12. Gilbert P.,Brewer N. T.,Reiter P. L.,Ng T. W.,Smith J. S.HPV vaccine acceptability in heterosexual, gay, and bisexual men.American Journal of Men's Health. 2011;5:297-305.
13. Montaño D. E.,Kasprzyk D.Health behavior and health education: Theory, research, and practice. 2008). Theory of reasoned action, theory of planned behavior, and the integrated behavioral model. In GlanzK.RimerB. K.VishwanathK. (Eds.), Health behavior and health education: Theory, research, and practice (4th ed., pp. 67-96). San Francisco, CA: Jossey-Bass.Glanz K.Rimer B. K.Vishwanath K., ed. San Francisco, CA: Jossey-Bass; 2008:67-96.
14. Guilano A. R.,Tortolero-Luna G.,Ferrer E.,Burchell A. N.,Sanjose S.,Kjaer S., Bosch F. X.Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions.Vaccine, 26. 2008;:K17-K28.
15. Hildesheim A.,Herrero R.Human papillomavirus vaccine should be given before sexual debut for maximum benefit.Journal of Infectious Diseases. 2007;196:1431-1432.
16. Hoy T.,Singhal P. K.,Willey V. J.,Insinga R. P.Assessing incidence and economic burden of genital warts with data from a US commercially insured population.Current Medical Research & Opinion. 2009;25:2343-2351.
17. Hu D.,Goldie S.The economic burden of noncervical human papillomavirus disease in the United States.American Journal of Obstetrics & Gynecology. 2008;198:500-507.
18. Jin F.,Prestage G. P.,Kippax S. C.,Pell C. M.,Donovan B.,Templeton D. J., Grulich A. E.Risk factors for genital and anal warts in a prospective cohort of HIV-negative homosexual men: The HIM study.Sexually Transmitted Diseases. 2007;34:488-493.
19. Jones M.,Cook R.Intent to receive an HPV vaccine among university men and women and implications for vaccine administration.Journal of American College Health. 2008;57:23-31.
20. Joseph D. A.,Miller J. W.,Wu X.,Chen V. W.,Morris C. R.,Goodman M. T., Cress R. D.Understanding the burden of human papillomavirus-associated anal cancers in the U.S.Cancer. 2008;113:S2892-S2900.
21. Kahn J. A.,Rosenthal S. L.,Jin Y.,Huang B.,Namakydoust A.,Zimet G. D.Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women.Obstetrics & Gynecology. 2008;111:1103-1110.
22. Katz M. L.,Krieger J. L.,Roberto A. J.Human papillomavirus (HPV): College male's knowledge, perceived risk, sources of information, vaccine barriers and communication.Journal of Men's Health. 2011;8:175-184.
23. Lenselink C. H.,Schmeink C. E.,Melchers W. J.,Massuger L. F.,Hendriks J. C.,van Hamont D.,Bekkers R. L.Young adults and acceptance of the human papillomavirus vaccine.Public Health. 2008;122:1295-1301.
24. Liddon N.,Hood J.,Wynn B. A.,Markowitz L. E.Acceptability of human papillomavirus vaccine for males: A review of the literature.Journal of Adolescent Health. 2010;46:113-123.
25. Parkin D. M.,Bray F.HPV and the burden of HPV-related cancers.Vaccine. 2006;24:S11-S25.
26. Petrovic K.,Burney S.,Fletcher J.The relationship of knowledge, health value and health self-efficacy with men's intentions to receive the human papillomavirus vaccine.Journal of Health Psychology. 2011;16:1-10.
27. Reiter P. L.,Brewer N. T.,McRee A.,Gilbert P.,Smith J. S.Acceptability of HPV vaccine among a national sample of gay and bisexual men.Sexually Transmitted Diseases. 2010;37:197-203.
28. Reiter P. L.,Brewer N. T.,Smith J. S.Human papillomavirus knowledge and vaccine acceptability among a national sample of heterosexual men.Sexually Transmitted Infections. 2010;86:241-246.
29. Reiter P. L.,McRee A. L.,Kadis J. A.,Brewer N. T.HPV vaccine and adolescent males.Vaccine. 2011;29:5595-5602.
30. Ryan G. W.,Bernard H. R.Techniques to identify themes.Field Methods. 2003;15:85-109.
31. Shiels M. S.,Pfeiffer R. M.,Gail M. H.,Hall I.,Li J.,Chaturvedi A., Engels E. A.Cancer burden in the HIV-infected population in the United States.Journal of the National Cancer Institute. 2011;103:753-762.
32. Simatherai D.,Bradshaw C. S.,Fairley C. K.,Bush M.,Heley S.,Chen M. Y.What men who have sex with men think about the human papillomavirus vaccine.Sexually Transmitted Infections. 2009;85:148-149.
33. U. S. Census Bureau. (2000). Poverty status in 1999 by age and by household type. U.S. Census 2000, Summary File 3. American FactFinder. Retrieved from http://factfinder.census.gov/servlet/MetadataBrowserServlet?type=DTtable&id=DEC_2000_SF3_U&table=DEC_2000_SF3_U_P089&_lang=en.
34. Woodhall S. C.,Jit M.,Cai C.,Ramsey T.,Zia S.,Crouch S.,Lacey C.Cost of treatment and QALYs lost due to genital warts: Data for the economic evaluation of HPV vaccines in the United Kingdom.Sexually Transmitted Diseases. 2009;36:515-521.